When should a medical device company hire a fractional CMO instead of a full-time CMO?

Most medical device companies between $3M and $40M in revenue cannot justify a full-time CMO ($280K to $500K loaded cost) but have outgrown the stage where the CEO can run marketing on the side. A fractional CMO fits the gap — strategic leadership at one to three days per week, 6 to 18 month engagements, $5K to $20K per month. Hire fractional when you need executive marketing thinking but the budget or revenue scale will not support a full-time hire for another 12 to 24 months. Upgrade to full-time when marketing complexity exceeds three days a week or when the company crosses roughly $40M to $50M in revenue.

What is the difference between a fractional CMO for medical device and a marketing consultant?

A consultant advises from outside — they deliver a strategy, a plan, or a recommendation, then leave execution to your team. A fractional CMO embeds inside the company. They sit in your leadership meetings, manage your marketing team or agency, own the budget, and are accountable for measurable commercial results. For medical device companies, the embedded model matters because marketing decisions touch sales, clinical, regulatory, and product teams every week — a consultant does not have the standing to drive cross-functional alignment, while a fractional CMO does.

What should a medical device fractional CMO accomplish in the first 90 days?

Days 1 to 30: marketing audit, sales-rep ride-alongs, KOL conversations, agency review, baseline KPI capture. Days 31 to 60: strategic plan with positioning, ICP, channel mix, budget allocation, and a 12-month roadmap aligned to product launch and reimbursement milestones. Days 61 to 90: launch the top 3 priority initiatives — typically a website rebuild or refresh, a sales enablement asset library, and a prioritized digital channel program. By day 90 the company should have measurement infrastructure live, a written strategy the CEO and head of sales agree on, and visible execution underway.

What questions should I ask when interviewing a fractional CMO for my medical device company?

Ask: How many medical device commercial launches have you led, and what classes (Class II/III, capital equipment, implant, IVD)? How do you align marketing with FDA and reimbursement timelines? Walk me through how you would build sales enablement for a surgeon-facing device. Which agencies and tech vendors do you have direct experience managing? How do you measure marketing's contribution to pipeline when the sales cycle is 9 to 18 months? Show me an example dashboard you have built. What does your day-to-day look like with a client at our stage? What would cause you to recommend ending the engagement?

How much does a fractional CMO for a medical device company cost?

Typical pricing for medical device fractional CMOs in 2026: $5,000 to $8,000 per month for one day per week, $8,000 to $15,000 per month for two days per week, and $12,000 to $20,000 per month for three days per week. Annualized, that is $60K to $240K versus $280K to $500K+ for a full-time CMO with benefits, bonus, and equity. Medical device fractional CMOs price at a premium over generalists because of the regulatory, clinical, and reimbursement knowledge required. Avoid pricing structures that bundle execution work into the leadership retainer — those tend to dilute strategic time.

Can a fractional CMO replace a marketing agency for a medical device company?

No — and a fractional CMO who tries to do both is a red flag. The fractional CMO sets strategy and manages execution. The execution itself — paid media, SEO, web build, video production, design, content — is delivered by an in-house team, an agency, or a combination. The right model for most $5M to $30M medical device companies is a fractional CMO plus one specialized healthcare marketing agency, with maybe one in-house marketing coordinator. The CMO directs the agency, the agency executes, and the company gets executive thinking and execution capacity at roughly half the cost of building both internally.

Fractional CMO for Medical Device: Hiring & 90-Day Playbook

If you are searching for a fractional CMO for medical device companies, you have probably already done the math — a full-time chief marketing officer costs $280,000 to $500,000+ when you load in benefits, bonus, and equity, and your revenue stage will not support that hire for another 12 to 24 months. Meanwhile, marketing is either running itself badly, eating CEO bandwidth that should be on capital raises and clinical evidence, or being passed back and forth between the head of sales and whichever junior employee has time. None of those work.

The fractional CMO model exists for exactly this gap. Done right, you get a senior medical device marketing operator embedded in the leadership team one to three days a week — strategy, agency management, sales enablement, launch leadership, and a budget owner — at 30 to 50% of the cost of a full-time hire. Done wrong, you pay $10K a month for a generalist who hands you a slide deck and a SWOT analysis, then disappears.

This guide is for medical device CEOs, founders, COOs, and VPs of Sales who are deciding whether to hire a fractional CMO and want to do it without the common mistakes. We cover when the model fits, what to look for, the interview questions that separate operators from talkers, what to expect in the first 90 days, and what success looks like at month 6 and month 12.

TL;DR

Right stage: $3M to $40M revenue, 6 to 18 months from a launch or a meaningful commercial inflection, marketing is leaderless or ad hoc.
Right scope: Strategy, team and agency management, launch leadership, sales enablement, budget ownership, KPI accountability — not execution.
Right specialization: Hire someone who has commercialized devices in your class — Class II/III, capital equipment, implant, IVD. Generalists cost more in the long run.
Right cadence: Two days a week is the sweet spot for most $5M to $25M companies. One day is light. Three days starts to overlap with full-time territory.
Right plan: Audit + strategy by day 60, top 3 initiatives launched by day 90, measurable commercial impact by month 6.

When the Fractional CMO Model Fits a Medical Device Company

The fractional model is not for every company at every stage. There are five situations where it consistently outperforms the alternatives:

You are between $3M and $40M in revenue. Below $3M, marketing is usually too immature to need executive leadership — a strong head of marketing or a senior consultant is enough. Above $40M, the marketing function has usually grown to the point where two to three days a week is no longer sufficient. The middle band is the sweet spot.

You are 6 to 18 months from a commercial inflection. An FDA clearance, a CPT code, a national contract, a Series B raise, or a meaningful product launch all create a step-change in marketing demand. A fractional CMO brought in 6 to 12 months before the inflection has time to build the foundation; brought in after, they are firefighting.

The CEO is still running marketing. This is the most common situation we see. The CEO has built the company on technical and clinical chops and has been deciding the marketing budget, picking the agency, and approving the website copy because no one else can. Every hour of CEO time spent on marketing is an hour not spent on capital, clinical, or partnerships.

Sales is generating its own marketing because nothing else is. Reps are building their own slides, asking for one-off case studies, and complaining about the corporate website at every QBR. There is no cohesive go-to-market story; there are 20 versions of one.

You have an agency that is underperforming and you do not know why. Without a marketing executive in-house, the agency operates without strategic direction. A fractional CMO inherits that agency relationship in week one and either fixes it or replaces it within 90 days.

What a Fractional CMO Actually Owns (and What They Do Not)

Scope clarity is the difference between a successful engagement and a frustrating one. A fractional CMO for a medical device company should own:

Strategy. Positioning, ICP definition, segmentation, channel mix, messaging frameworks, competitive narrative, the 12-month marketing roadmap.
Team and agency leadership. Hiring, mentoring, and managing in-house marketing staff. Selecting, briefing, reviewing, and replacing external healthcare marketing agencies.
Launch leadership. Pre-launch sequencing, launch-day execution, post-launch measurement and iteration. Cross-functional alignment with sales, clinical, regulatory, and reimbursement.
Sales enablement. Battle cards, value-prop decks, ROI calculators, clinical evidence packages, objection handling, KOL deployment. The fractional CMO should be in the field with reps in the first 60 days.
Budget and KPIs. Marketing budget ownership, reporting cadence, attribution model, board-ready dashboards.

What a good fractional CMO does not do: write blog posts, build landing pages, run paid search campaigns, design booths, or edit videos. Those are execution functions. If your fractional CMO is spending more than 10 to 15% of their time on execution, you are paying executive rates for senior-IC work and your strategy is starving.

What to Look for in a Medical Device Fractional CMO

The single best filter is direct device commercialization experience in your category. Medical device marketing is unlike consumer, B2B SaaS, or even most healthcare marketing. The buyer is a surgeon or a hospital committee, not a marketing director. The sales cycle is 6 to 18 months. Reimbursement determines adoption as much as clinical evidence. FDA approval timing controls the launch calendar. A fractional CMO who has not personally led a device launch will spend 90 days learning what your team already knows.

Specifically look for:

Three or more medical device commercial launches led personally, ideally in your class (Class II implant, Class III capital equipment, surgical instrument, IVD, etc.).
Direct experience managing healthcare marketing agencies, not just hiring them — knows what good output looks like and where agencies tend to underperform.
Reimbursement and HCEI literacy. Knows the difference between coverage, coding, and payment. Can read a sample CMS rule and understand what it means for messaging.
Sales partnership pattern. Has worked closely with VPs of Sales and surgeon-facing reps, ideally has done ride-alongs and case observations. Marketing that does not understand the rep's day will produce tools the rep will not use.
A track record of being fired in a healthy way. A fractional CMO who has never been transitioned out of an engagement either has not done enough engagements or is reluctant to make decisions that get them fired. Both are problems.

Avoid: generalist fractional CMOs without device experience; consultants who position themselves as fractional CMOs but have never been embedded in a leadership team; firms that staff three different people across one engagement; and anyone who quotes a price without first understanding your product, stage, and team.

Considering a Fractional CMO for Your Device Company?

45-min call. We walk through your stage, commercial timing, current marketing, and the specific gaps a fractional CMO would close — plus where the model is the wrong fit. You leave with a clear yes/no recommendation. No pitch.

Book the Call →

Interview Questions That Separate Operators From Talkers

Most fractional CMO interviews are too soft. The candidates are senior, the conversation is friendly, and you walk away with a positive feeling but no real signal. Use these questions to get past the polish:

Walk me through the last device launch you led, end to end. What was the product, what did you own, what worked, what did not, what would you do differently? You are listening for specifics. A real operator will name the agency partners, the launch metrics, and the painful surprises.
How would you align our marketing with our FDA and reimbursement timelines? A device CMO who cannot answer this fluently has not done the work.
Show me a sales enablement asset you built that the field actually used. Bring it to the next call. Hand-waving is disqualifying.
How do you measure marketing's contribution to pipeline when the sales cycle is 12 months? Listen for an honest answer about attribution complexity, not vendor-speak about MQLs.
Which agencies have you managed, and which would you fire and why? A candidate with no opinions about the agency landscape has not done the work.
What does your day-to-day look like with a $10M device company two days a week? A fictional candidate gives a generic answer; a real one walks you through Tuesday and Thursday with specifics.
What is the smallest engagement you would take, and why? Tells you whether they understand their own model.
What would cause you to recommend ending the engagement? A candidate who cannot name a clear exit signal will overstay.

The 90-Day Playbook

The first 90 days set the trajectory of the entire engagement. Here is what a strong fractional CMO will do:

Days 1 to 30: Listen, Audit, Ride Along

The first month is structured listening. Every leadership team meeting. Every sales QBR. Two to three days in the field with reps. Calls with the top 5 KOLs. A full audit of the website, the agency relationship, the existing collateral, the CRM data, the analytics and tracking infrastructure, the spend across channels, and the prior 12 months of marketing output. By day 30 the CMO should be able to write a one-page diagnosis of the marketing function — what is working, what is broken, what is missing — that the CEO and VP of Sales both nod at.

Days 31 to 60: Strategy and Alignment

Month two converts diagnosis into a written strategic plan. Positioning, ICP, segmentation, the 12-month roadmap, the channel mix, the agency recommendation, the budget allocation, the KPI framework, and the sales-marketing alignment model. The plan goes through one round of CEO and head-of-sales review and lands in week 8 as the operating document for the next year. Parallel to the strategy work, the CMO begins quick-win execution — the broken things that do not need a strategy to fix. Examples: a brutal trim of paid search waste, a sales enablement gap that is costing deals, a website page that is invisible on Google for the company's flagship product.

Days 61 to 90: Launch the Top 3 Initiatives

Month three turns the plan into visible motion. The fractional CMO launches the top three priority initiatives — typically some combination of a website overhaul kickoff, a sales enablement asset library, a digital channel program (often SEO plus a tightly scoped paid program), a launch readiness program for an upcoming product, or a measurement and analytics rebuild. By day 90 there is real momentum, the leadership team can see the new operating cadence, and the dashboard shows baseline metrics with targets attached.

What you should not see in the first 90 days: a slide deck and a status report and nothing else. If the engagement reaches day 90 without visible execution, it is in trouble.

Pricing, Structure, and Common Mistakes

Typical 2026 pricing for a medical device fractional CMO:

One day per week: $5,000 to $8,000 per month. Right for very small companies or for ongoing advisory after a heavier engagement winds down.
Two days per week: $8,000 to $15,000 per month. The most common engagement size for $5M to $25M device companies.
Three days per week: $12,000 to $20,000 per month. For companies in launch mode or with significant marketing complexity.

Structure best practices: 6-month minimum, monthly retainer billed on the 1st, defined scope in writing, a quarterly business review with the CEO, and a clear exit path. Avoid month-to-month engagements (the CMO will not invest in the harder strategic work) and avoid contracts that bundle execution work into the leadership rate (you will pay strategy rates for tactical hours).

The three most common mistakes companies make:

Hiring a generalist. A non-device fractional CMO will spend 90 days learning the market and another 90 ramping. By month 6 they will be where a device-specialist CMO was at month 1.
Underscoping. One day a week sounds cost-effective and rarely is. The CMO does not have enough time to embed, the team does not feel the leadership, and the engagement starves.
Not aligning with sales. A fractional CMO who reports to the CEO but does not have a tight working relationship with the head of sales will produce strategy the field ignores. Build the sales partnership in week one.

For a deeper read on the cost-and-ROI side of the model, see our companion guide on fractional CMO for medical devices: cost and ROI. For the broader marketing-leadership view, see proving marketing ROI as a medical device CMO and fractional marketing team for medical devices.

What Success Looks Like at 6 and 12 Months

By month 6, a fractional CMO engagement that is working will have produced: a written and adopted marketing strategy; a healthier agency relationship (or a new agency); a sales enablement library the field actively uses; visible improvement in pipeline contribution from marketing; a baseline-and-target KPI dashboard reviewed monthly; and a CEO who has reclaimed 5 to 10 hours a week previously spent on marketing decisions.

By month 12, the company should have measurable commercial outcomes attributable to the marketing rebuild — pipeline growth, faster sales cycles, higher rep productivity, a successful launch, or a clear quality-of-leads improvement — and the CEO should be able to make an informed decision about whether to extend the fractional engagement, transition to a full-time CMO, or scale the fractional engagement into a deeper integrated team via a model like a fractional marketing team.

The fractional CMO model is not a discount on a full-time hire. It is a different shape of leadership for a different stage of company. When the model fits — right stage, right scope, right operator, right plan — it is one of the highest-leverage hires a medical device CEO can make.

Fractional CMO for Medical Device: Hiring Guide and 90-Day Playbook